Have your say on Oral Immunotherapy (OIT) as a Possible Treatment for Food Allergy

Exploring Oral Immunotherapy (OIT) as a treatment option for children with food allergy

Oral Immunotherapy (OIT) is a potential treatment for food allergy but is not currently available in routine clinical practice in Australia. The Murdoch Children’s Research Institute is conducting a study which aims to understand the knowledge and attitudes of Australian families regarding OIT as a possible treatment for food allergy. The information received from this study (a survey) may be used to inform the development of OIT treatment trials for food allergy in Australia. 

If you are a parent/carer of a child/children with a food allergy (under 21 years old) please consider helping us by completing this survey. This survey is targeted to both families who have previous experience with OIT and those who do not have previous experience with OIT.

You can access the online survey via the following link: https://redcap.link/24o4klt7

_______________________________

The survey contains four main sections.

Section 1 focuses on your child/children’s food allergy history.

Section 2 asks about your previous experience with food allergy treatments.

Section 3 & 4 contains questions about your existing knowledge of OIT (if your family has never experienced OIT) or questions about your experiences with OIT (if your family has experience with OIT).

Section 5 aims to gather information about your goals, motivations and concerns regarding OIT.

The survey is voluntary. You can withdraw from the study at any time. Responses to the survey will remain anonymous (unless you wish to leave your contact details at the end of the survey for future contact by the study team). We expect this survey to take no more than 20-30 minutes to complete.

Please read the information statement in full before deciding whether or not to participate in this research. This information statement will appear when you click the link to the survey. If you require any further information regarding any aspect of this study please contact the researcher via the email address listed below.

Thank you for your participation.

 

If you have any questions about the study please contact:

A/Prof Kirsten Perrett

Co-group leader/Clinician-scientist, Centre for Food and Allergy Research, Murdoch Children’s Research Institute and Consultant Paediatrician, Department of Allergy and Immunology, Royal Children’s Hospital Melbourne

This email address is being protected from spambots. You need JavaScript enabled to view it.

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.